# Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects

> **NCT05239793** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Milton S. Hershey Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** NJOY e-cigarette

## Key facts

- **NCT ID:** NCT05239793
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-22
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05239793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05239793, "Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05239793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*